Last reviewed · How we verify
Yangzhengxiaoji Capsule
Yangzhengxiaoji Capsule is a traditional Chinese medicine formulation designed to support immune function and promote recovery in cancer patients.
Yangzhengxiaoji Capsule is a traditional Chinese medicine formulation designed to support immune function and promote recovery in cancer patients. Used for Supportive care in cancer patients, Cancer treatment-related side effect management.
At a glance
| Generic name | Yangzhengxiaoji Capsule |
|---|---|
| Sponsor | Shandong Cancer Hospital and Institute |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
Mechanism of action
This herbal capsule combines multiple botanical ingredients traditionally used in Chinese medicine to strengthen the body's vital energy (qi) and support immune function during and after cancer treatment. It is intended to help alleviate treatment-related side effects and improve overall quality of life in cancer patients, though its exact molecular mechanisms remain incompletely characterized by Western pharmacological standards.
Approved indications
- Supportive care in cancer patients
- Cancer treatment-related side effect management
Common side effects
Key clinical trials
- A Chinese Patent Medicine Yangzhengxiaoji Capsule to Improve the Nausea of Niraparib in the Maintenance Treatment in Ovarian Cancer (PHASE2)
- Treatment of Diffuse Large B Cell Lymphoma (PHASE4)
- Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Yangzhengxiaoji Capsule CI brief — competitive landscape report
- Yangzhengxiaoji Capsule updates RSS · CI watch RSS
- Shandong Cancer Hospital and Institute portfolio CI